ConductScience.org, home

Trial · NCT06507501

Effects of Exercise Training with Blood Flow Restriction

NCT06507501, Not applicable, Completed, Atlas University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effects of Exercise Training with Blood Flow Restriction. Trials, record NCT06507501. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06507501

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of Exercise Training with Blood Flow Restriction
NCT number
NCT06507501
Status
Completed
Phases
Not applicable
Enrollment
30 participants, actual
Lead sponsor
Atlas University
Conditions
Healthy
Interventions
Low Load Blood Flow Restriction Exercise Training (LL-BFRE), High Load Resistive Exercise Training (HL-RE)
First posted
2024-07-18
Last updated
2025-02-10

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMuscle StrengthBaseline to 6 weeks after exercise trainingKnee extansor and flexor muscle strength will be measured by using Hoggan Scientific; MicroFET2 brand hand-held dynamometer.
PrimaryDynamic BalanceBaseline to 6 weeks after exercise trainingDynamic balance will be assessed by using Y-Balance Test Lower Extremity.
PrimaryStatic BalanceBaseline to 6 weeks after exercise trainingStatic balance will be assessed by using Single Leg Stance Test with eyes open and closed.
SecondaryFuntional PerformanceBaseline to 6 weeks after exercise trainingFunctional performance will be assessed by using 6 Minute Walk Test.
SecondaryFuntional PerformanceBaseline to 6 weeks after exercise trainingFunctional performance will be assessed by using Single Leg Hop Test.
SecondaryCognitive PerformanceBaseline to 6 weeks after exercise trainingCognitive performance will be assessed by using Trail Making Test.
SecondaryCognitive PerformanceBaseline to 6 weeks after exercise trainingCognitive performance will be assessed by using Stroop Colour and Word Test.
OtherSociodemographic InformationBaseline
Age (years), gender, education level, smoking \& alcohol habits, whether they have a chronic disease, whether they use any medication, and exercise habits of the individuals participating in the study will be recorded.
OtherPhysical AssessmentBaseline
Height (cm), body weight (kg) and body mass index (BMI) (kg/m2) will be measured. Height will be measure via stadiometer, body weight will be measure via weighing device and BMI will be calculated using with the formula "weight/height (m)2".

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Stroop Color-Word TestSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06507501

GET https://conductscience.org/api/trials/v1/NCT06507501/registered